Movano Inc. (NASDAQ:MOVE – Get Free Report) CTO Michael Aaron Leabman sold 6,845 shares of the stock in a transaction that occurred on Wednesday, January 14th. The shares were sold at an average price of $6.66, for a total value of $45,587.70. Following the completion of the sale, the chief technology officer directly owned 22,639 shares of the company’s stock, valued at approximately $150,775.74. This represents a 23.22% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
Michael Aaron Leabman also recently made the following trade(s):
- On Tuesday, January 13th, Michael Aaron Leabman sold 2,076 shares of Movano stock. The shares were sold at an average price of $6.94, for a total value of $14,407.44.
- On Monday, January 12th, Michael Aaron Leabman sold 3,377 shares of Movano stock. The stock was sold at an average price of $7.01, for a total value of $23,672.77.
- On Friday, January 9th, Michael Aaron Leabman sold 783 shares of Movano stock. The shares were sold at an average price of $7.27, for a total transaction of $5,692.41.
- On Thursday, January 8th, Michael Aaron Leabman sold 3,593 shares of Movano stock. The shares were sold at an average price of $7.26, for a total transaction of $26,085.18.
- On Wednesday, January 7th, Michael Aaron Leabman sold 3,293 shares of Movano stock. The stock was sold at an average price of $7.34, for a total transaction of $24,170.62.
Movano Price Performance
NASDAQ:MOVE opened at $7.16 on Friday. The company’s 50-day moving average is $8.97 and its two-hundred day moving average is $7.56. Movano Inc. has a 1-year low of $4.67 and a 1-year high of $58.76. The firm has a market capitalization of $5.94 million, a price-to-earnings ratio of -0.66 and a beta of 0.79.
Institutional Trading of Movano
An institutional investor recently bought a new position in Movano stock. Citadel Advisors LLC bought a new stake in Movano Inc. (NASDAQ:MOVE – Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 49,262 shares of the technology company’s stock, valued at approximately $28,000. Citadel Advisors LLC owned about 5.94% of Movano at the end of the most recent reporting period. 16.64% of the stock is owned by institutional investors.
Trending Headlines about Movano
Here are the key news stories impacting Movano this week:
- Positive Sentiment: Institutional interest: Citadel Advisors disclosed a new, small stake in Movano (49,262 shares), which signals some institutional conviction and provides modest demand support for the thinly traded name. MarketBeat MOV E profile
- Positive Sentiment: Falling short interest: short interest declined in late December (helping reduce one technical headwind and lowering one source of immediate downside pressure). MarketBeat short interest
- Neutral Sentiment: Broader market/geopolitical weakness: wider market pullbacks and geopolitical headlines are hitting small-cap and tech names harder today, likely amplifying Movano’s move. This is a market-driven headwind rather than company-specific news. RTT News: Market Move
- Negative Sentiment: Clustered insider selling: CTO Michael Leabman sold multiple tranches this month (e.g., 6,845 shares on Jan. 14 at ~$6.66; additional sales Jan. 12–13). Large, concentrated insider sales in a tiny, low‑float stock weigh heavily on sentiment and can trigger further price pressure. SEC filing (Leabman)
- Negative Sentiment: Additional insider sales: CFO Jeremy Cogan also disclosed recent sales (including 8,218 shares on Jan. 6), further reducing insider ownership and reinforcing negative market perception. SEC filing (Cogan)
- Negative Sentiment: Weak fundamentals and tiny scale: the recent quarter showed a large EPS loss despite beating the consensus loss, with essentially negligible revenue (~$0.08M versus the street estimate). For a micro‑cap with a market cap in the single‑digit millions and low liquidity, execution risk and potential dilution remain real concerns. Earnings summary
- Negative Sentiment: Analyst/structural headwinds: small market cap, thin volume, and a consensus skewed toward “Sell” make sustained rebounds difficult absent clear operational progress or meaningful new revenue evidence. Company profile & ratings
Wall Street Analysts Forecast Growth
MOVE has been the subject of a number of recent analyst reports. Weiss Ratings reissued a “sell (e+)” rating on shares of Movano in a research report on Wednesday, October 8th. Wall Street Zen cut shares of Movano from a “hold” rating to a “sell” rating in a research report on Saturday. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, Movano currently has an average rating of “Sell”.
Check Out Our Latest Stock Report on Movano
Movano Company Profile
Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.
Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.
Read More
- Five stocks we like better than Movano
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Movano Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Movano and related companies with MarketBeat.com's FREE daily email newsletter.
